Bone Health Technologies takes a pivotal step toward a future of comprehensive one-stop bone health care for patients everywhere REDWOOD CITY, Calif. (July 25, 2024) – Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, today announced the company…
Read more
Bone Health Technologies (BHT) today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia…
Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia…
Bone Health Technologies (BHT) has been granted its fourth patent to further its commercialization of the Osteoboost device.
Osteoboost Reduced the Loss of Vertebral Bone Strength by 83% in One Year for Per Protocol Participants Vancouver, BC, Canada (October 13, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, is presenting top-line results from its pivotal trial for the Osteoboost at ASBMR…
Read more
